Bibliographic information

GuidelineWHO guidelines for malaria, 16 October 2023.
Year of Publication2023
Issuing InstitutionWorld Health Organization

Recommendation

New

Infants weighing < 5 kg with uncomplicated P. falciparum malaria should be treated with an ACT at the same mg/kg bw target dose as for children weighing 5 kg. *Not evaluated using the GRADE framework

Recommended in favor

Strong

Notes and Remarks

Practical info The pharmacokinetics properties of many medicines in infants differ markedly from those in adults because of the physiological changes that occur in the first year of life. Accurate dosing is particularly important for infants. The only antimalarial agent that is currently contraindicated for infants (< 6 months) is primaquine. ACT is recommended and should be given according to body weight at the same mg/kg bw dose for all infants, including those weighing < 5 kg, with close monitoring of treatment response. The lack of infant formulations of most antimalarial drugs often necessitates division of adult tablets, which can lead to inaccurate dosing. When available, paediatric formulations and strengths are preferred, as they improve the effectiveness and accuracy of ACT dosing.